Paradigm Biopharmaceuticals Limited

ASX:PAR 주식 보고서

시가총액: AU$77.1m

Paradigm Biopharmaceuticals 배당금

배당금 기준 확인 0/6

Paradigm Biopharmaceuticals does not have a record of paying a dividend.

주요 정보

n/a

배당 수익률

-39.1%

환매 수익률

총 주주 수익률-39.1%
미래 배당 수익률n/a
배당금 성장n/a
다음 배당금 지급일n/a
전 배당일n/a
주당 배당금n/a
지급 비율n/a

최근 배당금 업데이트

업데이트 없음

Recent updates

Paradigm Biopharmaceuticals (ASX:PAR) Is In A Strong Position To Grow Its Business

Aug 22
Paradigm Biopharmaceuticals (ASX:PAR) Is In A Strong Position To Grow Its Business

Here's Why We're Not At All Concerned With Paradigm Biopharmaceuticals' (ASX:PAR) Cash Burn Situation

Apr 17
Here's Why We're Not At All Concerned With Paradigm Biopharmaceuticals' (ASX:PAR) Cash Burn Situation

Companies Like Paradigm Biopharmaceuticals (ASX:PAR) Are In A Position To Invest In Growth

Sep 21
Companies Like Paradigm Biopharmaceuticals (ASX:PAR) Are In A Position To Invest In Growth

Here's Why We're Not Too Worried About Paradigm Biopharmaceuticals' (ASX:PAR) Cash Burn Situation

Jun 20
Here's Why We're Not Too Worried About Paradigm Biopharmaceuticals' (ASX:PAR) Cash Burn Situation

Companies Like Paradigm Biopharmaceuticals (ASX:PAR) Are In A Position To Invest In Growth

Dec 02
Companies Like Paradigm Biopharmaceuticals (ASX:PAR) Are In A Position To Invest In Growth

Companies Like Paradigm Biopharmaceuticals (ASX:PAR) Are In A Position To Invest In Growth

Jun 07
Companies Like Paradigm Biopharmaceuticals (ASX:PAR) Are In A Position To Invest In Growth

Is Paradigm Biopharmaceuticals Limited (ASX:PAR) Trading At A 46% Discount?

Feb 22
Is Paradigm Biopharmaceuticals Limited (ASX:PAR) Trading At A 46% Discount?

We're Not Worried About Paradigm Biopharmaceuticals' (ASX:PAR) Cash Burn

Jan 24
We're Not Worried About Paradigm Biopharmaceuticals' (ASX:PAR) Cash Burn

Did You Participate In Any Of Paradigm Biopharmaceuticals' (ASX:PAR) Incredible 811% Return?

Dec 28
Did You Participate In Any Of Paradigm Biopharmaceuticals' (ASX:PAR) Incredible 811% Return?

When Will Paradigm Biopharmaceuticals Limited (ASX:PAR) Turn A Profit?

Nov 29
When Will Paradigm Biopharmaceuticals Limited (ASX:PAR) Turn A Profit?

결제의 안정성과 성장

배당금 데이터 가져오기

안정적인 배당: Insufficient data to determine if PAR's dividends per share have been stable in the past.

배당금 증가: Insufficient data to determine if PAR's dividend payments have been increasing.


시장 대비 배당 수익률

Paradigm Biopharmaceuticals 시장 대비 배당 수익률
PAR 배당 수익률은 시장과 어떻게 비교되나요?
세그먼트배당 수익률
회사 (PAR)n/a
시장 하위 25% (AU)2.6%
시장 상위 25% (AU)6.1%
업계 평균 (Biotechs)2.2%
애널리스트 예측 (PAR) (최대 3년)n/a

주목할만한 배당금: Unable to evaluate PAR's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

고배당: Unable to evaluate PAR's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


주주에 대한 수익 배당금

수익 보장: Insufficient data to calculate PAR's payout ratio to determine if its dividend payments are covered by earnings.


주주에 대한 현금 배당금

현금 흐름 범위: Unable to calculate sustainability of dividends as PAR has not reported any payouts.


강력한 배당금 지급 기업 알아보기